Quantum BioPharma Signs Binding Letter Of Intent With Allucent To Conduct Phase 2 Clinical Trial In Multiple Sclerosis Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM)

#QNTM Quantum BioPharma Signs Binding Letter Of Intent With Allucent To Conduct Phase 2 Clinical Trial In Multiple Sclerosis

www.stocktitan.net/news/QNTM/quantum-bio-ph...

Quantum Biopharma’s 2025 Audited Year End Financial Results Maintain ‘No Going Concern’ Status {"summary":"","positive":[],"negative":[],"faq":[]}

#QNTM Quantum Biopharma’s 2025 Audited Year End Financial Results Maintain ‘No Going Concern’ Status

www.stocktitan.net/news/QNTM/quantum-biopha...

Quantum BioPharma Announces Peer-Reviewed Journal Publication of Groundbreaking Clinical Trial With Unbuzzd Quantum BioPharma (NASDAQ: QNTM) announced a peer‑reviewed publication (World Journal of Pharmaceutical and Medical Research, March 23, 2026) reporting a double‑blind, randomized, placebo‑controlled crossover trial of its dietary supplement unbuzzd.Key findings: >40% faster reduction in blood alcohol concentration within 30 minutes, improved alertness and physiologic stability, 67% reduction in headache severity at four and eight hours, and no reported adverse side effects.

#QNTM Quantum BioPharma Announces Peer-Reviewed Journal Publication of Groundbreaking Clinical Trial With Unbuzzd

www.stocktitan.net/news/QNTM/quantum-bio-ph...

Inspired by the novel There Is No Antimemetic Division by Sam Hughes

#aiart #aiphotography #books #qntm

"𝘐 𝘳𝘦𝘮𝘦𝘮𝘣𝘦𝘳 𝘸𝘰𝘳𝘬𝘪𝘯𝘨..."

#aiart #books #qntm #scifi

Unauthorized cover art #3 for Sam Hughes' 𝘛𝘩𝘦𝘳𝘦 𝘐𝘴 𝘕𝘰 𝘈𝘯𝘵𝘪𝘮𝘦𝘮𝘦𝘵𝘪𝘤𝘴 𝘋𝘪𝘷𝘪𝘴𝘪𝘰𝘯

There Is No Antimemetics Division: Review & Analysis A requiem for the forgotten

There Is No Antimemetics Division. Anymore?

Today I gave a review & analysis to one of my favourite reads of the year so far, a book that takes science fiction in fascinating new directions!

proseandcontext.substack.com/p/there-is-n...

#sff #booksky #qntm #scp #bookreview

Finally read after a long wait. Quite and interesting read. Looking forward to his next book

#booksky #QNTM #reading

The Weekly Short Stack for January 16, 2026 Each week, I pull together a short stack of the things that stood out -- something I made, something I read or watched, an experience that left a small but noticeable impression in the week. Not a gra...

This week’s Short Stack:
• collaborative music
• creative shortcuts
• tension on screen
• dread on the page

Not a recap. Just what lingered long enough to write down.
👉 www.jnassi.com/the-weekly-s...

#writing #writinglife #weeklyreflection #vibecoding #martysupreme #jamvote #qntm #antimemetics

A book held open by a hand. The pages are heavily redacted with black text blocks, only some words are visible.

My book is turning into the epstein files #thereisnoantimemeticsdivision #qntm

There Is No Antimemetics Division — ⭐️⭐️⭐️⭐️⭐️
Mind‑bending, unforgettable, and impossible to put down.I just finished and posted a review with Goodreads. Head on over and check it out.

www.goodreads.com/review/show/...

#ThereIsNoAntimemeticsDivision #Qntm #Antimemetics #CosmicHorror #HorrorBooks

aéPiot - Bluesky Profile Full Transparency with aéPiot: Natural Semantics | MultiSearch | Search | Tag Explorer | MultiLingual | RSS Reader | RSS Feed Manager | FREE Back Link | MultiLingual Related Report - aepiot.ro - allgr...

blueskystarterpack.com/profile/aepiot.bsky.social

#ELEVEN #STRANGER #THINGS
multi-search-tag-explorer.aepiot.ro/advanced-sea...
#QNTM
headlines-world.com/advanced-sea...

aepiot.com

Cover of the book "There is no anti memetics division"

Well this is even more wild than I was expecting. Hugely enjoyable scifi mind-melter. #ThereIsNoAntiMemeticsDivision #qntm

Best book of the year for me. I read over 190 books so far this year, and I think this book really does hit a brilliant, magnificent level. It is creepy and smart. It also reflects life back to us, similar to 1984 or Handmaid's Tale. I've been recommending to everyone.
#qntm #antimemetics

If there is any such division, of course. How would I know, anyway.

BTW, recommending „There is no Antimemetic Division“ by #qntm .
Great read, man!

#QNTM Investigative News Program W5 Airs Final Segment on USD $700 Million Stock Market Manipulation Lawsuit of Quantum Biopharma Involving CIBC and RBC

www.stocktitan.net/news/QNTM/investigative-...

Quantum Biopharma’s USD $700 Million Lawsuit Alleging Stock Market Manipulation Subject of 3-part Series Investigative News Program W5 {"summary":"","positive":[],"negative":[],"faq":[]}

#QNTM Quantum Biopharma’s USD $700 Million Lawsuit Alleging Stock Market Manipulation Subject of 3-part Series Investigative News Program W5

www.stocktitan.net/news/QNTM/quantum-biopha...

Quantum Biopharma’s USD $700 Million Lawsuit Alleging Stock Market Manipulation Subject of 3-part Series Investigative News Program W5 {"summary":"","positive":[],"negative":[],"faq":[]}

#QNTM Quantum Biopharma’s USD $700 Million Lawsuit Alleging Stock Market Manipulation Subject of 3-part Series Investigative News Program W5

www.stocktitan.net/news/QNTM/quantum-biopha...

#bookmail 😍 📚

#lonelymotel #duncanralston #ThereIsNoAntimemeticsDivision #qntm #SciFiBooks #horrorbooks #bookmailisthebestmail

When that preorder finally knocks at your door, late one gloomy November evening. Very excited #ThereIsNoNoAntimemeticsDivision #qntm

Quantum BioPharma Announces Cash Reward of up to USD $7Million for Proof of Market Manipulation in its Stock Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) (“ Quantum BioPharma ” or the

#QNTM Quantum BioPharma Announces Cash Reward of up to USD $7Million for Proof of Market Manipulation in its Stock

www.stocktitan.net/news/QNTM/quantum-bio-ph...

Quantum BioPharma: Engineering the Digital Balance Sheet in Life Sciences A Vanderbilt Report View Quantum BioPharma (NASDAQ:QNTM) presents a hybrid issuer model combining neuroscience drug development, consumer-health commercialization, and market-access technology to create a "digital balance-sheet framework."Key elements: flagship neuroprotective program Lucid-MS (Lucid-21-302), a PET imaging collaboration with Massachusetts General Hospital to track remyelination, a consumer brand Celly Nu with the unbuzzd beverage (royalty: 7% until $250M paid, then 3% in perpetuity), and a dual listing on Upstream approved in January 2025 to enable near-instant settlement and broader investor access.

#QNTM Quantum BioPharma: Engineering the Digital Balance Sheet in Life Sciences A Vanderbilt Report View

www.stocktitan.net/news/QNTM/quantum-bio-ph...

First-in-Class MS Treatment: Quantum BioPharma's Lucid-21-302 Completes Critical Safety Studies for FDA Biotech firm receives final 90-day oral toxicity and toxicokinetic study reports for Lucid-MS, a novel demyelination-targeting MS treatment, advancing toward IND application and Phase 2 trials.

#QNTM Quantum BioPharma Receives Final Reports for Two Key Studies of its Potential Breakthrough Drug for Multiple Sclerosis, Moving Closer to Phase 2 Clinical Trial

www.stocktitan.net/news/QNTM/quantum-bio-ph...

450+ Published Research Papers: Leading MS Expert Dr. Jack Antel Joins Quantum BioPharma's Clinical Team Dr. Jack Antel, former ACTRIMS President with 450+ publications, joins Quantum BioPharma to guide Phase 2 trials of Lucid-MS demyelination inhibitor drug candidate.

#QNTM Quantum BioPharma Welcomes World-Renowned Multiple Sclerosis Expert Dr. Jack Antel as Clinical Development Advisor For Lucid-MS Trials

www.stocktitan.net/news/QNTM/quantum-bio-ph...

Quantum BioPharma Announces Corporate Updates Quantum BioPharma (NASDAQ: QNTM), a biopharmaceutical company focused on neurodegenerative and metabolic disorders, announced several corporate updates. The company settled $26,812.50 USD in debt through the issuance of 1,102 Class B Shares at $24.33 USD per share.The Board granted 800 RSUs each to Clinical Advisors Peter Stys and Jack Antel, with vesting tied to regulatory milestones for Lucid MS clinical trials. Additionally, Kevin Malone's Board Advisor Agreement was terminated effective August 15, 2025.

#QNTM Quantum BioPharma Announces Corporate Updates

www.stocktitan.net/news/QNTM/quantum-bio-ph...

Quantum BioPharma Announces Update to Previously Announced Private Placement Quantum BioPharma (NASDAQ: QNTM) has announced updates regarding its previously disclosed non-brokered private placement. The company will seek shareholder approval for the offering of class A multiple voting shares (MVS) at its upcoming annual general meeting on September 26, 2025. The private placement aims to raise gross proceeds of up to $600.The offering is expected to be primarily subscribed by existing MVS holders and will include a statutory hold period of four months plus one day. The proceeds will be used for general working capital purposes. The securities being offered will not be registered under the U.S. Securities Act of 1933 and cannot be sold in the United States without registration or exemption. ["Company is raising additional working capital through private placement", "Existing MVS holders expected to participate, showing continued investor confidence"]

#QNTM Quantum BioPharma Announces Update to Previously Announced Private Placement

www.stocktitan.net/news/QNTM/quantum-bio-ph...

Truth Be Told - The Fremont Frat House YouTube video by sunnycorax

This week on Truth Be Told, we will be covering Tesla #TSLA newest lawsuit & the Fremont Frat House, the potential #FMCC #FNMA IPO, and the meme stock shenanigans of #BINI / #MULN, #GNS, and #QNTM and much more.

@platinumsparkles.bsky.social @thatgirltrader.bsky.social

youtube.com/live/nV08692...

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Commences Reg D Capital Raise Campaign to Fund Growth and Possible IPO Quantum BioPharma (NASDAQ: QNTM) announced that its licensee, Unbuzzd Wellness Inc., has launched a Regulation D 506(c) offering to raise up to $5.0 million. The capital raise will fund growth initiatives and establish a path toward a potential IPO, without diluting Quantum BioPharma shareholders.Quantum BioPharma maintains a 25% ownership stake in Unbuzzd through an anti-dilution provision until Unbuzzd reaches a $1 billion valuation. Unbuzzd has partnered with MZ Digital and Dealmaker for the capital raise campaign, accepting both traditional and cryptocurrency payments through ALT5 Pay's platform.Unbuzzd is led by CEO John Duffy, former Coca-Cola VP, and Board Co-Chair Gerry David, former CEO of Celsius Holdings. The company produces unbuzzd™, a functional beverage designed to accelerate alcohol metabolism and reduce hangover symptoms.

#QNTM Quantum BioPharma Licensee Unbuzzd Wellness Inc. Commences Reg D Capital Raise Campaign to Fund Growth and Possible IPO

www.stocktitan.net/news/QNTM/quantum-bio-ph...

Friday night I joined Tony & Mike to discuss if Kevin Malone's promotion of #GNS and #QNTM crosses the line. Is Malone like your average paid stock promoter, or does his activities constitute something more nefarious?

youtu.be/q2jxrbiZ5ig

New First-in-Class Multiple Sclerosis Treatment Advances Toward Fast-Track UK Approval Revolutionary MS treatment Lucid-21-302 enters UK's innovative licensing pathway. First-in-class drug targets novel demyelination mechanism. Learn development timeline.

#QNTM Quantum BioPharma Submits its Candidate Breakthrough Patented Drug for Multiple Sclerosis for Fast-Track Program in the United Kingdom

www.stocktitan.net/news/QNTM/quantum-bio-ph...

#QNTM dilutes and suddenly Great Value Zach Morris aka Kevin Malone goes radio silent while the company removes him as an advisor to the board.